Karl Dhaene
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 5%
- Surgery top 5%
- Neurology top 2%
- Molecular Biology
- Co-authors
- Uğur ŞahinÖzlem TüreciEric Van MarckMichael KoslowskiClaudio PasqualiSergio PedrazzoliFabrizio MichelassiGünter Klöppel
- Topics
- Telomeres, Telomerase, and Senescence (6 papers)Occupational and environmental lung diseases (6 papers)Pancreatic and Hepatic Oncology Research (5 papers)
- Cited by
- NeurologyOncologyGastroenterology
In The Last Decade
Karl Dhaene
30 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 1.1k
- Pulmonary and Respiratory Medicine 810
- Surgery 631
- Neurology 430
- Molecular Biology 382
Countries citing papers authored by Karl Dhaene
This map shows the geographic impact of Karl Dhaene's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Dhaene with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Dhaene more than expected).
Fields of papers citing papers by Karl Dhaene
This network shows the impact of papers produced by Karl Dhaene. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Dhaene. The network helps show where Karl Dhaene may publish in the future.
Co-authorship network of co-authors of Karl Dhaene
This figure shows the co-authorship network connecting the top 25 collaborators of Karl Dhaene. A scholar is included among the top collaborators of Karl Dhaene based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Dhaene. Karl Dhaene is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinomabreakdown → | 244 |
| 2 | 161 | |
| 3 | 16 | |
| 4 | PD-L1 testing for non-small cell lung cancer : Belgian guidelines | 1 |
| 5 | Pathological diagnosis and molecular testing in non-small cell lung cancer: Belgian guidelines | 4 |
| 6 | 32 | |
| 7 | 79 | |
| 8 | 54 | |
| 9 | 28 | |
| 10 | 39 | |
| 11 | 6 | |
| 12 | 18 | |
| 13 | 128 | |
| 14 | 23 | |
| 15 | 2 | |
| 16 | 21 | |
| 17 | 2 | |
| 18 | 93 | |
| 19 | Standard Versus Extended Lymphadenectomy Associated With Pancreatoduodenectomy in the Surgical Treatment of Adenocarcinoma of the Head of the Pancreasbreakdown → | 523 |
| 20 | 24 |
About Karl Dhaene
Karl Dhaene is a scholar working on Gastroenterology, Neurology and Biotechnology, having authored 30 papers that have together received 2.1k indexed citations. Recurring topics across this work include Telomeres, Telomerase, and Senescence (6 papers), Occupational and environmental lung diseases (6 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Neurology (430 citations), Oncology (1.1k citations) and Gastroenterology (185 citations). Karl Dhaene has collaborated with scholars based in Belgium, Germany and Czechia. Frequent co-authors include Uğur Şahin, Özlem Türeci, Eric Van Marck, Michael Koslowski, Claudio Pasquali, Sergio Pedrazzoli, Fabrizio Michelassi, Günter Klöppel, V. DiCarlo and Renzo Dionigi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.